ID: ALA156311
Chembl Id: CHEMBL156311
PubChem CID: 44370564
Max Phase: Preclinical
Molecular Formula: C21H25N5O2
Molecular Weight: 379.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCOC(=O)c1ccc(NCc2ccc3nc(N)nc(N)c3c2C)cc1
Standard InChI: InChI=1S/C21H25N5O2/c1-3-4-11-28-20(27)14-5-8-16(9-6-14)24-12-15-7-10-17-18(13(15)2)19(22)26-21(23)25-17/h5-10,24H,3-4,11-12H2,1-2H3,(H4,22,23,25,26)
Standard InChI Key: RODHXFIBTQVISM-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 379.46 | Molecular Weight (Monoisotopic): 379.2008 | AlogP: 3.67 | #Rotatable Bonds: 7 |
| Polar Surface Area: 116.15 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 3 |
| #RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: ┄ | CX Basic pKa: 7.54 | CX LogP: 4.08 | CX LogD: 3.71 |
| Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.42 | Np Likeness Score: -0.77 |
| 1. Crippen GM.. (1980) Quantitative structure-activity relationships by distance geometry: systematic analysis of dihydrofolate reductase inhibitors., 23 (6): [PMID:7392027] [10.1021/jm00180a004] |
| 2. Ghose AK, Crippen GM.. (1982) Quantitative structure-activity relationship by distance geometry: quinazolines as dihydrofolate reductase inhibitors., 25 (8): [PMID:7120278] [10.1021/jm00350a003] |
| 3. Hansch C, Fukunaga JY, Jow PY.. (1977) Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines., 20 (1): [PMID:319234] [10.1021/jm00211a020] |
Source(1):
